LOBLAW COS LTD/ CA5394811015 /
31/05/2024 08:14:27 | Var. +2.0000 | Volume | Denaro21:59:38 | Lettera21:59:38 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
105.0000EUR | +1.94% | 0 Fatturato: 0.0000 |
-Quantità in denaro: - | -Quantità in lettera: - | 33.83 bill.EUR | - | - |
GlobeNewswire
22:33
Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor’s...
GlobeNewswire
22:30
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
GlobeNewswire
22:30
Vision Sensing Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Initial Bus...
GlobeNewswire
22:15
Earlyworks and ZenmuTech collaborate for a more secure digital society through secret splitting and ...
GlobeNewswire
22:10
Consolidated Water Announces Partial Adjournment of Annual General Meeting and Information for Recon...
GlobeNewswire
22:07
Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferr...
GlobeNewswire
22:05
TEN, Ltd. Announces Date of First Quarter 2024 Results, Conference Call and Webcast
GlobeNewswire
22:05
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc....
GlobeNewswire
22:05
Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire
22:01
Wayne Savings Bancshares, Inc. and Main Street Financial Services Corp. Complete Merger
GlobeNewswire
22:01
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)